BIOMAT Database Logo BIOMAT Database Logo

Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells. 2003

Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
The First Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

Akt is known to be activated in the rheumatoid synovial tissues. We examined here functional role of Akt during tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis in rheumatoid synovial cells. Rheumatoid synovial cells in vitro were rapidly committed to apoptosis in response to TRAIL in mitochondria-dependent manner whereas Akt and extracellular signal-regulated kinase (ERK) were also phosphorylated. TRAIL-mediated apoptosis in synovial cells was significantly increased through inactivation of Akt by LY294002, however, that process was not so changed by adding ERK inhibitor, PD98059. Platelet-derived growth factor (PDGF) clearly phosphorylated both Akt and ERK in synovial cells, and PDGF pretreatment markedly suppressed TRAIL-mediated synovial cell apoptosis. The use of not PD98059 but LY294002 abrogated PDGF-mediated inhibitory effect toward TRAIL-induced apoptosis in synovial cells. The above protective effect of Akt was confirmed by the use of short interfering RNA (siRNA)-directed inhibition of Akt. Our data suggest that Akt is an endogenous inhibitor during TRAIL-mediated synovial cell apoptotic pathway, which may explain that synovial cells in situ of the rheumatoid synovial tissues are resistant toward apoptotic cell death in spite of death receptor expression.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
November 2003, Arthritis and rheumatism,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.
September 2005, The American journal of pathology,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells.
May 2000, Cancer research,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL).
January 2014, Advances in experimental medicine and biology,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.
January 2003, Cancer research,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
September 2005, Cancer research,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
October 2005, Human pathology,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer.
September 2013, Oncology letters,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis.
July 2002, The Journal of biological chemistry,
Taiichiro Miyashita, and Atsushi Kawakami, and Mami Tamai, and Yasumori Izumi, and Huang Mingguo, and Fumiko Tanaka, and Seigou Abiru, and Koto Nakashima, and Nozomi Iwanaga, and Koichiro Aratake, and Makoto Kamachi, and Kazuhiko Arima, and Hiroaki Ida, and Kiyoshi Migita, and Tomoki Origuchi, and Shuzo Tagashira, and Fumio Nishikaku, and Katsumi Eguchi
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells.
May 2007, Carcinogenesis,
Copied contents to your clipboard!